FDA Monthly Preview: Key June Decisions to Watch - Top-Institutions - MDSpire

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

  • By

  • Kathryn Wighton

  • May 29, 2026

  • 3 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    UCSF–Stanford Center of Excellence in Regulatory Science and Innovation
    UCSF–Stanford Center of Excellence in Regulatory Science and Innovation

    San Francisco, CA

    Key Differentiators

    • Regulatory Science
    • Pharmacology

  • #2

    Johns Hopkins University CERSI
    Johns Hopkins University CERSI

    Baltimore, MD

    Key Differentiators

    • Regulatory Science
    • Public Health

Original Source(s)

FDA Monthly Preview: Key June Decisions to Watch

  • by Kathryn Wighton

  • May 29, 2026

Related Content

Comparison of the therapeutic performance of macrolide antibiotics on macrolide-resistant or macrolide-susceptible Mycoplasma pneumoniae pneumonia children

Hantavirus Outbreak Revives COVID-Era False Health Claims — The Monitor

Analysis of pathogen distribution and association with lipid levels in patients with diabetic foot